D. Matthew Shoemaker
Impact in
-
- Antibiotic Use and Resistance
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Pneumocystis jirovecii pneumonia detection and treatment 1
- Co-authors
- William Salzer (2 shared papers)John Williamson (1 shared paper)Dima Dandachi (1 shared paper)Rebecca Reece (1 shared paper)Nathan C. Bahr (1 shared paper)Karen Snyder (1 shared paper)Andrew Moore (1 shared paper)B Leyland-Jones (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Open Forum Infectious Diseases (2 papers)The Journal of Rural Health (1 paper)Vector-Borne and Zoonotic Diseases (1 paper)Therapeutics and Clinical Risk Management (1 paper)
- Partner nations
- United States
In The Last Decade
D. Matthew Shoemaker
9 papers receiving 300 citations
Peers
Comparison fields: 5 of 69
- Applied Microbiology and Biotechnology 24
- Molecular Medicine 48
- Pharmacology 140
- Nephrology 37
- Clinical Biochemistry 25
Countries citing papers authored by D. Matthew Shoemaker
This map shows the geographic impact of D. Matthew Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Matthew Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Matthew Shoemaker more than expected).
Fields of papers citing papers by D. Matthew Shoemaker
This network shows the impact of papers produced by D. Matthew Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Matthew Shoemaker. The network helps show where D. Matthew Shoemaker may publish in the future.
Co-authors
The 17 scholars most cited alongside D. Matthew Shoemaker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 209 | |
| 2 | 2006 | 29 | |
| 3 | 2020 | 23 | |
| 4 | Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent. | 1986 | 22 |
| 5 | 2023 | 12 | |
| 6 | 2022 | 6 | |
| 7 | 2024 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2006 | 1 | |
| 10 | 2022 | 0 |
About D. Matthew Shoemaker
D. Matthew Shoemaker is a scholar working on Pharmacology, Epidemiology, Infectious Diseases, Immunology and Critical Care and Intensive Care Medicine, having authored 10 papers that have together received 306 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Antibiotic Use and Resistance (1 paper), Plant Pathogens and Fungal Diseases (1 paper), Forensic Entomology and Diptera Studies (1 paper), Antifungal resistance and susceptibility (1 paper), Diptera species taxonomy and behavior (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (24 citations), Molecular Medicine (48 citations), Pharmacology (140 citations), Nephrology (37 citations) and Clinical Biochemistry (25 citations). D. Matthew Shoemaker has collaborated with scholars based in United States. Frequent co-authors include William Salzer, John Williamson, Dima Dandachi, Rebecca Reece, Nathan C. Bahr, Karen Snyder, Andrew Moore, B Leyland-Jones, Mary K. Wolpert-DeFilippes and Richard B. Moon. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, The Journal of Rural Health, Vector-Borne and Zoonotic Diseases and Therapeutics and Clinical Risk Management.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.